Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 7, Issue 12, Pages e2505-e2505
Publisher
Springer Nature
Online
2016-12-01
DOI
10.1038/cddis.2016.395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma
- (2015) J. J. Shah et al. CLINICAL CANCER RESEARCH
- Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors
- (2015) J. Sarantopoulos et al. CLINICAL CANCER RESEARCH
- Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation
- (2015) Jian An et al. MOLECULAR CELL
- SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression
- (2015) Wenjian Gan et al. MOLECULAR CELL
- Protein neddylation: beyond cullin–RING ligases
- (2015) Radoslav I. Enchev et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis
- (2015) A. Lunardi et al. Cancer Discovery
- Induction of p21-Dependent Senescence by an NAE Inhibitor, MLN4924, as a Mechanism of Growth Suppression
- (2015) Lijun Jia et al. NEOPLASIA
- Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy
- (2014) Yongchao Zhao et al. ANTIOXIDANTS & REDOX SIGNALING
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF- B Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
- (2014) J. C. Godbersen et al. CLINICAL CANCER RESEARCH
- The small-molecule inhibitor selectivity between IKKαand IKKβkinases in NF-κB signaling pathway
- (2014) Feifei Tian et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Androgen Suppresses the Proliferation of Androgen Receptor-Positive Castration-Resistant Prostate Cancer Cells via Inhibition of Cdk2, CyclinA, and Skp2
- (2014) John M. Kokontis et al. PLoS One
- Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition ofc-MYCtranscription
- (2014) Lizamma Antony et al. PROSTATE
- Suppression of tumor angiogenesis by targeting the protein neddylation pathway
- (2014) W-T Yao et al. Cell Death & Disease
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer
- (2013) L. Wu et al. CANCER RESEARCH
- Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins
- (2013) Nathan W. Pierce et al. CELL
- Building and remodelling Cullin-RING E3 ubiquitin ligases
- (2013) John R Lydeard et al. EMBO REPORTS
- Evaluation of ERG responsive proteome in prostate cancer
- (2013) Shyh-Han Tan et al. PROSTATE
- The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
- (2012) Z. Luo et al. CANCER RESEARCH
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
- (2012) C Mackintosh et al. ONCOGENE
- Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis
- (2012) Y Zhao et al. Cell Death & Disease
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover
- (2011) M. A. Milhollen et al. CANCER RESEARCH
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
- (2011) K. A. Bridges et al. CLINICAL CANCER RESEARCH
- MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma
- (2010) M. A. Milhollen et al. BLOOD
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
- (2010) Jianghua Wang et al. CANCER RESEARCH
- NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
- (2010) J. J. Lin et al. CANCER RESEARCH
- ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence
- (2009) L. Jia et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen
- (2009) J. Mullenders et al. CLINICAL CANCER RESEARCH
- Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
- (2009) Michael J. Morris et al. EUROPEAN UROLOGY
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Targeting the ubiquitin system in cancer therapy
- (2009) Daniela Hoeller et al. NATURE
- A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
- (2009) S. Sur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
- (2008) J. Wang et al. CANCER RESEARCH
- TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
- (2008) C Sun et al. ONCOGENE
- PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)
- (2008) B. M. Emerling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started